It has been shown that high levels of MCL-1 expression are required for B-lymphoma cell survival (62) and correlate with high-grade lymphoma (63), suggesting an association between high levels of MCL-1 expression and progressive disease (64). This evidence concerns the gene MCL1 and lymphoma.